Lazard, Inc. LAZ ← Back to all reports

Lazard, Inc.

LAZ · Financials
B ★★★ Hold
Aug 19, 2026 · Score 77 · Type A — Value-style analysis Used for established, cash-generative companies — weighs earnings power, valuation against the company's own history and peers, and margin of safety. Full methodology →
Current PriceThe market price around the time this report was written — not a live quote. The market has moved since; check a current price before acting.Methodology → $44.64
Buy ZoneThe large figure is the midpoint of the suggested buy range shown in parentheses. $41.00 ($39.00–$43.00)
Price TargetOur estimated fair value. For richly valued stocks it can sit below the current price — see Methodology.Methodology → $55.25
Expected Return
  • Target relative to the Current Price ((Target − Current) ÷ Current). Since that price is from the report date, your actual return will differ.
  • A negative figure isn't an error. For richly valued stocks, the fair-value target can sit below the current price, so the return reads negative. The grade reflects company quality; this figure reflects today's entry valuation.
Methodology →
+23.8%

Type A - Lazard, Inc. (LAZ) 20260819 Stock Analysis

📅 Lazard Key Upcoming Events

🏢 Step 1: Lazard Company Overview & Business Model

Q1-A1. What is Lazard?

Q1-A2. How Does Lazard Make Money?

Q1-A3. Lazard’s Revenue Segments & Core Income Sources

Q1-A4. Who Are Lazard’s Competitors?

Q1-A5. Lazard Key Events: Past 12 Months

Q1-A6. Step 1 Key Takeaways

🏰 Step 2: Lazard’s Economic Moat, Growth & Capital Allocation

Q2-A1. Does Lazard Have a Durable Economic Moat?

Q2-A2. Is Lazard’s Growth Sustainable?

Q2-A3. How Does Lazard Allocate Capital & Return Cash?

Q2-A4. Step 2 Key Takeaways

💰 Step 3: Is Lazard Profitable? Financial Health Analysis

Q3-A2. How Profitable Is Lazard? (Margins & ROIC)

Q3-A3. What Drives Lazard’s Returns? (ROIC Breakdown)

Q3-A4. Are Lazard’s Earnings High Quality?

Q3-A5. Is Lazard’s Balance Sheet Healthy? (Debt & Leverage)

Q3-A6. Step 3 Key Takeaways

🔎 Step 4: Lazard Forensic Accounting & Dilution Review

Q4-A1. Does Lazard Have Accounting Red Flags?

Q4-A2. Is Lazard Overspending? (Capex & Capital Cycle)

Q4-A3. How Sound Is Lazard’s Cash Flow?

Q4-A4. Is Lazard Diluting Shareholders?

Q4-A5. Data Integrity Check

Q4-A6. Step 4 Key Takeaways

👔 Step 5: Lazard Management & Shareholder Alignment

Q5-A1. Can You Trust Lazard’s Management? (Guidance Track Record)

Q5-A2. What Are Lazard Insiders Doing?

Q5-A3. Is Lazard’s Management Aligned With Shareholders?

Q5-A4. Step 5 Key Takeaways

⛵ Step 6: Lazard Market Flow & Sentiment

Q6-A1. Analyst Consensus vs Lazard Guidance

Q6-A2. What Is Lazard’s Short Interest?

Q6-A3. Step 6 Key Takeaways

🚀 Step 7: Lazard Catalysts & Price Triggers

Q7-A1. What Could Move Lazard Stock? (Top 3 Catalysts)

Q7-A2. Lazard’s Earnings Revision Trend

Q7-A3. Step 7 Key Takeaways

⚖️ Step 8: Is Lazard Fairly Valued? Valuation Analysis

Q8-A1. Lazard’s Key Valuation Multiples (P/E, EV/EBITDA)

Q8-A2. Lazard vs Peers: Valuation Comparison

Q8-A3. Is Lazard Cheap or Expensive vs Its History?

Q8-A4. What Growth Is Priced Into Lazard? (Reverse DCF)

Q8-A4-1. What Growth Hurdle Does the Market Demand From Lazard? (Reverse DCF Alternative)

Q8-A5. Valuation Cross-Check

Q8-A6. Lazard’s Hidden Asset & Stake Valuation

Q8-A7. Final Valuation Adjustment

Q8-A8. Valuation Adjustment Score Calculation

💀 Step 9: What Are the Risks of Lazard? Fatal Risks & Pre-Mortem

Q9-A1. What Are the Biggest Risks to Lazard?

Q9-A2. How Sensitive Is Lazard to the Economy?

Q9-A3. Lazard Pre-Mortem: What Could Go Wrong?

Q9-A4. Risk Adjustment Score

🎯 Step 10: Lazard Final Verdict: Score & Rating

Q10-A1. Investment Score & Rating

Q10-A2. Should You Buy Lazard? (Recommendation)

Q10-A3. Investment Thesis in One Line

Q10-A4. Lazard’s Price Trend & Key Drivers

Q10-A5. Action Plan

🕵️‍♂️ Deep Dive Analysis

Q1: Is Lazard’s Heavy Reliance on Human Capital and Elevated Compensation Ratios Its Biggest Weakness?

Q2: Can Lazard’s 13.4x Forward P/E Be Justified Amidst an Erratic M&A Recovery?

Q3: Will the $575 Million Campbell Lutyens Acquisition Truly Transform Lazard’s Advisory Trajectory?

Q4: Does the Surging Asset Management Division Mask Underlying Weaknesses in Core Advisory?

Q5: Is Lazard’s Generous Dividend Policy Safe from the Current Profitability Squeeze?

Q6: Can Lazard Maintain Its Prestigious Independence Amidst Consolidation in the Boutique Banking Sector?

Q7: Will the C-Corp Conversion Materially Expand Lazard’s Institutional Shareholder Base?

Q8: Does the 69.7% Adjusted Tax Rate in Q2 2026 Signal a Permanent Structural Flaw?

Q9: Is Lazard’s Heavy European Footprint a Liability or a Strategic Advantage?

Q10: Can CEO Peter Orszag Successfully Execute the “Lazard 2030” Vision Amidst Current Margin Chaos?